Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer

International Journal of Cancer

Volumn 87, Issue 5, 2000, Pages 637-643

  Spurdle, Amanda B ^a   Webb, Penelope M ^a   Chen, Xiaoqing ^a   Martin, Nicholas G ^a   Giles, Graham G ^c   Hopper, John L ^b   Chenevix Trench, Georgia ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c University of Melbourne ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; EXON; FEMALE; GENE MUTATION; HORMONE ACTION; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; REGRESSION ANALYSIS; SARCOMERE LENGTH; TANDEM REPEAT;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; EXONS; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; RISK FACTORS; TRINUCLEOTIDE REPEATS; TWINS, MONOZYGOTIC;

EID: 0033865368     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000901)87:5<637::AID-IJC3>3.0.CO;2-R     Document Type: Article

References (34)

1. AL-TIMIMI A., BUCKLEY C.H. and Fox H., An immunohistochemical study of the incidence and significance of sex steroid hormone binding sites in normal and neoplastic human ovarian tissue. Int. J. Gynecol. PathoL., 4, 24-41 (1985).
2. AUSTRALIAN INSTITUTE OF HEALTH AND WELFARE (AIHW) AND AUSTRALASIAN ASSOCIATION OF CANCER REGISTRIES (AACR). Cancer in Australia 1995: Incidence and mortality data for 1995 unit selected data for 1996. AIHW cat. No. CAN 5. (Cancer Series No. 10). Australian Institute of Health and Welfare, Canberra (1998).
3. BERCHUCK, A., KOHLER, M.F., MARKS, J.R., WISEMAN, R., BOYD, J. and BAST, R.C., The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am. J. Obstet. Gynecol., 170, 246-252 (1994).
4. BOYD, J. and RUBIN S.C., Hereditary ovarian cancer: molecular genetics and clinical implications. Gyn. Ooncol., 64, 196-206 (1997).
5. CHAMBERLAIN, N.L., DRIVER, E.D. and MIESFIELD, R.L., The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucl. Acids Res., 22, 3181-3186 (1994).
6. CHENEVIX-TRENCH, G., KERR, J., HURST, T., SHIH, Y-C., PURDIE, D., BERGMAN, L., FRIEDLANDER, M., SANDERSON, B., ZOURNAZI, A., COOMBS, T., LEARY, J.A., CRAWFORD, E., SHELLING, A.N., COOKE, I., GANESAN, T.S., SEARLE, J., CHOI, C., BARRETT, J.C., KHOO, S-K. and WARD, B., Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: clinicopathological correlations. Genes Chrom. Cancer, 18, 75-83 (1997).
7. EDWARDS, A., HAMMOND, H.A., JIN, L., CASKEY, C.T. and CHAKRABORTY, R., Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics, 12, 241-253 (1992).
8. FUJITA, M., ENOMOTO, T., YOSHINO, K., NOMURA, T., BUZARD, G.S., INOUE, M. and OKUDAIRA Y., Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer. Int. J. Cancer, 64, 361-366 (1995).
9. GAYTHER, S.A., RUSSELL, P., HARRINGTON, P., ANTONIOU, A.C., EASTON, D.H. and PONDER, B.A.J., The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am. J. Hum. Genet., 65, 1021-1029 (1999).
10. GIOVANUCCI, E., STAMPFER, M.J., KRITHIVAS, K., BROWN, M., BRIESKY, A., TALCOTT, J., HENNEKENS, C.H. and KANTOFF, P.W., The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl. Acad Sci. USA, 94, 3320-3323 (1997).
11. GIOVANNUCCI, E., PLATZ, E.A., STAMPFER, M.J., CHAN, A., KRITHIVAS, K., KAWACHI, I., WILLETT, W.C. and KANTOFF, P.W., The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology, 53, 121-125 (1999).
12. HAKIMI, J.M., SCHOENBERG, M.P., RONDINELLI, R.H., PIANTADOSI, S. and BARRACK, E.R., Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin. Cancer, Res., 3, 1599-1608 (1997).
13. HARDY, D.O., SCHER, H.I., BOGENREIDER, T., SABBATINI, P., ZHANG. Z.F., NANUS, D.M. and CATTERALL, J.F., Androgen receptor CAG repeat lengths in prostate cancer: correlation with age at onset. J. Clin. Endocrinol. Metab., 81, 4400-4405 (1996).
14. HEATH, A.C., BUCHOLZ, K.K., MADDEN, P.A., DINWIDDIE, S.H., SLUTSKE, W.S., BIKRUT, L.J., STATHAM, D.J., DUNNE, M.P., WHITFIELD, J.B. and MARTIN, N.G., Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men. Psychol. Med., 27, 1381-1396 (1998).
15. HELZLSOUER, K.J., ALBERG, A.J., GORDON, G.B., LONGCOPE, C., BUSH, T.L., HOFFMAN, S.C. and COMSTOCK, G.W., Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA, 274, 1926-1930 (1995).
16. ICHIKAWA, Y., NISHIDA, M., SUZUKI, H., YOSHIDA, S., TSUNODA, H., KUBO, T., UCHIDA, H. and MIWA, M., Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumours. Cancer Res., 54, 33-35 (1994).
17. INGLES, S.A., ROSS, R.K., YU, M.C., IRVINE, R.A., LA PERA, G., HAILE, R.W. and COETZEE, G.A., Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J. Natl. Cancer, Inst., 89, 166-170 (1997).
18. IRVINE, R.A., YU, M.C., ROSS, R.K. and COETZEE, G.A., The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res., 55, 1937-1940 (1995).
19. KVALE, G., HEUCH, I., NILSSON, S. and BERAL, V., Reproductive factors and risk of ovarian cancer: a prospective study. Int. J. Cancer, 42, 246-251 (1988).
20. LA SPADA, A.R., WILSON, E.M., LUBAHN, D.B., HARDING, A.E. and FISCHBECK, K.H., Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature, 352, 77-79 (1991).
21. MACLEAN, H.E., CHOI, W.T., REKARIS, G., WARNE, G.L. and ZAJAC, J.D., Abnormal androgen receptor binding affinity in subjects with Kennedy's disease (spinal and hulbar muscular atrophy). J. Clin Endocrinol. Metab., 80, 508-516 (1995).
22. MCCREDIE, M.R., DITE, G., GILES, G.G. and HOPPER, J.L., Breast cancer in Australian women under the age of 40. Cancer Cause Control, 9, 189-198 (1998).
23. MILLER, S.A., DYKES, D.D. and POLESKY, H.F., A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res., 16, 1215 (1988).
24. OBATA, K., MORLAND, S.J., WATSON, R.H., HITCHCOCK, A., CHENEVIX-TRENCH, G., THOMAS, E.J. and CAMPBELL, I.G., Frequent PTEN/MMAC mutations in endometriod but not serous or mucinous epithelial ovarian tumours. Cancer Res., 58, 2095-2020 (1998).
25. PARAZZINI, F., FRANCKSCHI, S., LA VECCHIA, C. and FASOLI, M., The epidemiology of ovarian cancer. Gynecol. Oncol., 43, 9-23 (1991).
26. PETTERSSON, F., Annual report on gynaecologic cancer of FIGO (Vol 20). Panorama Press, Stockholm (1988).
27. PURDIE, D., GREEN, A., BAIN, C.. SISKIND, V., WARD, B., HACKER, N., QUNII, M., WRIGHT, G., RUSSELL, P. and SUSIL, B., Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group. Int. J. Cancer, 15, 678-684 (1995).
28. REBBECK, T.R., KANTOFF, P.W., KRITHIVAS, K., NEUHAUSEN, S., BLACKWOOD, M.A., GODWIN, A.K., DALY, M.B., NAROD, S.A., GARBER, J.E., LYNCH, H.T. WEBER, B.L. and BROWN, M., Modification of BRCA1-associated breast cancer risk by the polymorphic androgen receptor CAG repeat. Am. J. Hum. Genet., 64, 1371-1377 (1999).
29. RISCH, H.A., Hormonal Etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl. Cancer. Inst., 90, 1774-1786 (1998).
30. SILVA, E.G., TORNOS, C., FRITSCHE, H.A. JR, EL-NAGGAR, A., GRAY, K., ORDONEZ, N.G., LUNA, M. and GERSHENSON, D., The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. Mod. Pathol., 10, 879-883 (1997).
31. SPURDLE, A.B., DITE, G.S., CHEN, X., MAYNE, C.J., SOUTHEY, M.C., BATTEN, L., CHY, H., TRUTE, L., MCCREDIE, M.R.E., GILES, G.G., ARMES, J., VENTER, D.J., HOPPER, J.L. and CHENEVIX-TRENCH, G., Androgen Receptor Exon 1 CAG repeat length and breast cancer in women before age forty years. J. Natl. Cancer Inst., 91, 961-966 (1999).
32. STANFORD, J.L., JUST, J.J., GIBBS, M., WICKLUND, K.G., NEAL, C.L., BLUMENSTEIN, B.A. and OSTRANDER, E.A., Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res., 57, 1194-1198 (1997).
33. STRATTON, J.F., GAYTHER, S.A., RUSSEL, P., DEARDEN, J., GORE, M., BLAKE, P., EASTON, D. and PONDER, B.A.J., Contribution of BRCAI mutations to ovarian cancer. New Engl. J Med., 336, 1125-1130 (1997).
34. TUT, T.G., GHADESSY, F.J., TRIFIRO, M.A., PINSKY, L. and YONG, E.L., Long polyglutamine tracts in the androgen receptor are associated with reduced transactivation, impaired sperm production, and male infertility. J Clin. Endocrinol. Metab., 82, 3777-3782 (1997).